U.S. Microbics {BUGS} - Environmental Augmentation

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks U.S. Microbics {BUGS} - Environmental Augmentation

Previous 10 Next 10

To: BRSteve who wrote (303)	3/31/1999 2:00:00 PM
From: Sigmund	of 345

Company can not spell. Company can not meet deadlines Company not always straight with its shareholders or simply not competent with the English language (a possibility) Company has shareholders from former life who sell on each rise Shares (preferred) are issued to pay current bills That is the negative. The positive is: Seems to have a good product in a growing market R&D management excellent CEO can't spell, write, or manage but he has a vision and I have confidence in his ability to eventually make BUGS a very big success. I am looking for a big success here....but my track record is not that great. I am an investor in Acumed, so no one should pay any attention to anything that I say.

Share	RecommendKeepReply Mark as Last Read Read Replies (1)

To: Sigmund who wrote (305)	3/31/1999 2:42:00 PM
From: BRSteve	of 345

Sigmund, well I'm in Acumed, too. Can't win them all. I hope we have a real winner here. Yours, Steve

Share	RecommendKeepReply Mark as Last Read Read Replies (1)

To: BRSteve who wrote (306)	3/31/1999 3:52:00 PM
From: Frank Buck	of 345

AccuMed.... pitoooeee^... ... If we had taken our collective money out of AccuFed last spring and parked that money into BUGS... we could have aggregately made enough cash to buy a controlling interest in AccuDom. But then 51% of nothing is still nothing isn't it?

Share	RecommendKeepReply Mark as Last Read Read Replies (1)

To: Frank Buck who wrote (307)	4/7/1999 1:02:00 AM
From: Sigmund	of 345

three months is a long time to wait. and then we may just get another excuse, weasel worded.

Share	RecommendKeepReply Mark as Last Read Read Replies (1)

To: Sigmund who wrote (308)	4/8/1999 6:54:00 PM
From: Frank Buck	of 345

"three months is a long time to wait." Three months.... let's see what happens in April and May with the Seminars. Did you see the picture of the Bio Raptor? bugsatwork.com Yes indeed.... "excuses" are like anal orphices.... everyone has them.

Share	RecommendKeepReply Mark as Last Read Read Replies (1)

To: Frank Buck who wrote (309)	4/9/1999 1:07:00 AM
From: Sigmund	of 345

Yes the seminars. Strange for a company to be conducting sales seminars if there is a line waiting to buy the product. I want to see some serious financing.

Share	RecommendKeepReply Mark as Last Read Read Replies (1)

To: Sigmund who wrote (310)	4/9/1999 9:27:00 AM
From: Frank Buck	of 345

I want to see some serious financing. Have you spoken or written to Brehm lately to see what is happening?

Share	RecommendKeepReply Mark as Last Read Read Replies (1)

To: Frank Buck who wrote (311)	4/9/1999 11:38:00 AM
From: BRSteve	of 345

There's been a lack of news here, except for the Arthur Anderson announcement. I hope at the seminar next week, there will be some information release on pending sales and shipments of product. We need something to stimulate interest in BUGS! Yours, Steve

Share	RecommendKeepReply Mark as Last Read Read Replies (1)

To: BRSteve who wrote (312)	4/9/1999 5:01:00 PM
From: Sigmund	of 345

talk about being volatile. wonder what is going on.

Share	RecommendKeepReply Mark as Last Read Read Replies (2)

To: Sigmund who wrote (313)	4/9/1999 5:17:00 PM
From: Frank Buck	of 345

U.S. Microbicssees FY 99 EPS $0.50-$1.00 CARLSBAD, Calif., Nov 20 (Reuters) - U.S. Microbics said Friday that net income for its fiscal year ending September 10, 1999, will range between $0.50 and $1.00 per share, while revenues reach at least $30 million. The company, a marketer of proprietary microbial technologies for environmental cleanup, said it will begin filling a $30 million product backlog on December 15, when its new Carlsbad facility begins full operations. Products will be shipped to customers in the commercial, industrial, agricultural and municipal markets. Based on market conditions, the company said it could achieve revenues of up to $100 million by 2002.

Share	RecommendKeepReply Mark as Last Read